The role of CD95 and CD95 ligand in cancer
2015 · Cell Death and Differentiation · 336 citations
https://doi.org/10.1038/cdd.2015.3
A
Andrea E. Murmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
3.3K
Citations
22
h-index
31
i10-index
Andrea E. Murmann is an academic researcher from Northwestern University. The author has contributed to research in topics: MicroRNA in disease regulation & RNA Interference and Gene Delivery & RNA Research and Splicing. The author has an h-index of 22, co-authored 65 publications.
ORCID: 0000-0001-7321-1528Papers by this author
worksCD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response
2017 · Cell Reports · 109 citations
https://doi.org/10.1016/j.celrep.2017.02.037
Death Induced by CD95 or CD95 Ligand Elimination
2014 · Cell Reports · 83 citations
https://doi.org/10.1016/j.celrep.2014.02.035
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
2021 · iScience · 17 citations
https://doi.org/10.1016/j.isci.2021.103348
Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging
2024 · Nature Communications · 13 citations
https://doi.org/10.1038/s41467-023-44465-8
DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases
2021 · Journal of Experimental & Clinical Cancer Research · 11 citations
https://doi.org/10.1186/s13046-021-02177-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat